The China plus one strategy encourages diversification of suppliers due to geopolitical risks, which benefits Indian companies across various sectors. In pharma, both traditional and CDMO segments show opportunities. The industrial sector grows more attractive as interest rates drop and currency stabilizes. The strategy also provides a competitive edge to Indian exporters facing Chinese competition.
MCX shares gain 3%, surge 12% in just 5 sessions. What’s behind the sharp rally?
MCX shares rose sharply on Wednesday, extending a five-day rally with total gains of 12%. The surge is driven by rising commodity prices and higher